EP500 - ECE_1831 - Semaglutide rewires thyroid transcriptional programs in obesity through sex-specific modulation of adiponectin signaling and mTOR–RET pathways
Year: 2026
Type: conference-abstract
Abstract: Background Obesity disturbs endocrine homeostasis and reshapes thyroid-specific transcriptional programs. Recent data show a higher prevalence of thyroid dysfunction and atypical TSH profiles in obese individuals, highlighting the clinical relevance of metabolic–thyroid crosstalk. Given the widespread use of semaglutide, this study investigates its sex-specific impact on thyroid gene regulation in obese rats. Methods Male and female Wistar rats were exposed to an eight-week high-fat/fructose diet combined with L-NAME to induce obesity (n = 6 per group). Animals were subsequently randomized to semaglutide (Sema) or saline, while lean controls received standard chow without L-NAME. After additional eight weeks, thyroid tissue was analyzed by qRT-PCR for metabolic and thyroid-specific marker genes. Serum adiponectin and leptin were quantified. Results The adiponectin receptor emerged as an obesity-sensitive target, with males showing significant upregulation in mRNA expression vs controls (P < .05) and a trend toward Sema-mediated downregulation (P = .09). In females, Sema significantly suppressed adiponectin receptor expression (P < .05). In males, obesity downregulated mTOR, Cxcl10 and Foxe1 (P < .01), key regulators of thyroid hormone synthesis and metabolic signaling. Sema restored these transcripts (P < .05), suggesting a reversal of obesity-induced thyroid dysfunction. Sema also reduced Rps6ka4 expression in males (P < .05), pointing to a positive modulation of stress-responsive pathways. In contrast, obese females exhibited a significant upregulation of RET (P < .05). In males, adiponectin/leptin ratio was significantly higher in obese compared to lean rats, reduced in Sema, but without effects in females. Conclusions Semaglutide reprograms thyroid transcriptional networks in obesity via sex-specific modulation of adiponectin signaling and metabolic stress pathways, revealing a previously underappreciated endocrine interface between semaglutide and thyroid regulation.
Institution: Universitätsklinikum Würzburg
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,292
OpenAlex ID: W7213338165
